相关实验视频
Updated: Jun 6, 2025

07:57
A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
20.8K
总抗氧化能力与抑郁症患病率之间的关联:NHANES 2007-2018年
1Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, 130021, PR China.
Journal of psychiatric research
|November 29, 2024
概括
较高的总抗氧化能力与较低的抑郁风险有关. 这种联系在没有高血压的个体中更为强烈,突出了抗氧化剂在心理健康中的作用.
科学领域:
- 营养流行病学 营养流行病学
- 心理健康研究 心理健康研究
- 氧化压力研究 研究 氧化压力研究
背景情况:
- 抑郁症是一个重大的全球公共卫生挑战,发病率和复发率很高.
- 虽然氧化应激和抑郁有联系,但总抗氧化能力的影响仍未得到充分探索.
- 现有研究尚未充分研究整体抗氧化能力与抑郁症患病率之间的关系.
研究的目的:
- 检查总抗氧化能力和抑郁症患病率之间的横截面关联.
- 研究总抗氧化能力与其他暴露,包括性别之间的潜在相互作用.
- 为了确定抗氧化能力是否影响抑郁症的风险,在不同的人口群体中存在差异.
主要方法:
- 利用了2007-2018年国家健康和营养检查调查 (NHANES) 的数据.
- 包括24,375名参与者的大量样本大小,以便进行可靠的分析.
- 使用复合饮食抗氧化剂指数 (CDAI) 和氧化平衡得分 (OBS) 来量化抗氧化能力,通过二进制后勤回归分析与抑郁症的关联.
主要成果:
- 无论是CDAI还是OBS,都显示出与抑郁症患病率有显著的反向关联 (P < 0.05).
- 观察到OBS和高血压之间的相互作用 (P-相互作用=0.043),但与性别或其他变量没有相互作用.
- 较高的OBS水平与抑郁症的几率降低相关,特别是在没有高血压的人群中.
结论:
- 提高总抗氧化能力显著与抑郁症的几率降低有关.
- 在被研究的人群中,OBS和高血压之间存在着显著的相互作用.
- 在没有高血压的人群中,OBS和抑郁症之间的保护性关联比患有高血压的人群更明显.
相关概念视频
Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49
Depression: Overview
216
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
216
Stress and Mental Health
77
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
77
Human Genetics
535
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
535
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194

